Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome

Diabetes

Volumn 62, Issue 3, 2013, Pages 845-854

  Xue, Peng ^a   Hou, Yongyong ^a   Chen, Yanyan ^a,b   Yang, Bei ^a   Fu, Jingqi ^a,b   Zheng, Hongzhi ^a,b   Yarborough, Kathy ^a   Woods, Courtney G ^a   Liu, Dianxin ^a   Yamamoto, Masayuki ^a   Zhang, Qiang ^a,b   Andersen, Melvin E ^a   Pi, Jingbo ^a  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUCOSE; INSULIN; LEPTIN; LIPID; MESSENGER RNA; TRANSCRIPTION FACTOR NRF2;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; ENERGY BALANCE; FEMALE; GENE EXPRESSION; GLUCOSE TRANSPORT; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LEPTIN DEFICIENCY; LIPID TRANSPORT; LIPOGENESIS; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE EXPANSION; WHITE ADIPOSE TISSUE; WILD TYPE;

ADIPOGENESIS; ADIPOSE TISSUE, WHITE; ADIPOSITY; ANIMALS; CROSSES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MICE; MICE, KNOCKOUT; MICE, OBESE; NF-E2-RELATED FACTOR 2; OBESITY; ORGAN SPECIFICITY; OXIDATIVE STRESS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 84873336694     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0584     Document Type: Article

References (47)

1. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006;444:847-853
2. Vigouroux C, Caron-Debarle M, Le Dour C, Magré J, Capeau J. Molecular mechanisms of human lipodystrophies: From adipocyte lipid droplet to oxidative stress and lipotoxicity. Int J Biochem Cell Biol 2011;43:862-876
3. Virtue S, Vidal-Puig A: Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim Biophys Acta 2010;1801:338-349
4. Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol 1995;15:4184-4193
5. Kobayashi M, Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul 2006;46:113-140
6. Thimmulappa RK, Lee H, Rangasamy T, et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 2006;116:984-995
7. Motohashi H, O'Connor T, Katsuoka F, Engel JD, Yamamoto M. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 2002;294:1-12
8. Itoh K, Mimura J, Yamamoto M. Discovery of the negative regulator of Nrf2, Keap1: A historical overview. Antioxid Redox Signal 2010;13:1665-1678
9. Cho HY, Reddy SP, Kleeberger SR. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal 2006;8:76-87
10. Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997;236:313-322
11. Pi J, Leung L, Xue P, et al. Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J Biol Chem 2010;285:9292-9300
12. Hou Y, Xue P, Bai Y, et al. Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein b during adipogenesis. Free Radic Biol Med 2012;52:462-472
13. Garg A, Agarwal AK: Lipodystrophies: Disorders of adipose tissue biology. Biochim Biophys Acta 2009;1791:507-513
14. Florenza CG, Chou SH, Mantzoros CS. Lipodystrophy: Pathophysiology and advances in treatment. Nat Rev Endocrinnol 2011;7:137-150
15. Chatterjee R, Bhattacharya P, Gavrilova O, et al. Suppression of the C/EBP family of transcription factors in adipose tissue causes lipodystrophy. J Mol Endocrinol 2011;46:175-192
16. Pi J, Bai Y, Daniel KW, et al. Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic beta-cell function. Endocrinology 2009;150:3040-3048
17. Sajic T, Hopfgartner G, Szanto I, Varesio E. Comparison of three detergentfree protein extraction protocols for white adipose tissue. Anal Biochem 2011;415:215-217
18. Pi J, Qu W, Reece JM, Kumagai Y, Waalkes MP. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: Involvement of hydrogen peroxide. Exp Cell Res 2003;290:234-245
19. Chartoumpekis DV, Ziros PG, Psyrogiannis AI, et al. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes 2011;60: 2465-2473
20. Medina-Gomez G, Gray SL, Yetukuri L, et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 2007;3:e64
21. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191-1212
22. McMahon M, Itoh K, Yamamoto M, et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 2001; 61:3299-3307
23. Sekhar KR, Spitz DR, Harris S, et al. Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase. Free Radic Biol Med 2002;32:650-662
24. Lee TD, Yang H, Whang J, Lu SC. Cloning and characterization of the human glutathione synthetase 59-flanking region. Biochem J 2005;390:521-528
25. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002;62: 5196-5203
26. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444: 860-867
27. Czech MP. Fat targets for insulin signaling. Mol Cell 2002;9:695-696
28. Tontonoz P, Spiegelman BM. Fat and beyond: The diverse biology of PPARgamma. Annu Rev Biochem 2008;77:289-312
29. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006;7:885-896
30. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006;4:263-273
31. Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab 2009;20:107-114
32. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995;9:168-181
33. Wu Z, Rosen ED, Brun R, et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 1999;3:151-158
34. Zhang J, Fu M, Cui T, et al. Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity. Proc Natl Acad Sci USA 2004;101:10703-10708
35. Yamauchi T, Waki H, Kamon J, et al. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J Clin Invest 2001; 108:1001-1013
36. Rieusset J, Touri F, Michalik L, et al. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Mol Endocrinol 2002;16:2628-2644
37. Kubota N, Terauchi Y, Miki H, et al. PPAR gamma mediates high-fat dietinduced adipocyte hypertrophy and insulin resistance. Mol Cell 1999;4: 597-609
38. Miles PD, Barak Y, He W, Evans RM, Olefsky JM. Improved insulinsensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest 2000;105:287-292
39. Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998;20:284-287
40. Gray SL, Nora ED, Grosse J, et al. Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 2006;55:2669-2677
41. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114: 1752-1761
42. Pi J, Bai Y, Zhang Q, et al. Reactive oxygen species as a signal in glucosestimulated insulin secretion. Diabetes 2007;56:1783-1791
43. Goldstein BJ, Mahadev K, Wu X, Zhu L, Motoshima H. Role of insulininduced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal 2005;7:1021-1031
44. Lee H, Lee YJ, Choi H, Ko EH, Kim JW. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J Biol Chem 2009;284:10601-10609
45. Goldstein BJ, Mahadev K, Wu X. Redox paradox: Insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005;54:311-321
46. Kim J, Cha YN, Surh YJ. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 2010;690: 12-23
47. Wruck CJ, Streetz K, Pavic G, et al. Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter. J Biol Chem 2011;286:4493-4499